Actively Recruiting
Decision-Making in Schizophrenia: A Combined Neuroimaging and Experience Sampling Study
Led by Rutgers, The State University of New Jersey · Updated on 2026-03-11
74
Participants Needed
1
Research Sites
129 weeks
Total Duration
On this page
Sponsors
R
Rutgers, The State University of New Jersey
Lead Sponsor
N
National Institute of Mental Health (NIMH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn if attention and ways of thinking impact decision-making and brain processes related to decision-making in people with schizophrenia or schizoaffective disorder relative to people without either condition. It will also learn how brain functioning during decision-making relates to real-world decisions made during daily life. The main questions it aims to answer are: * Does paying attention to specific information impact decision-making and brain processes? * Does thinking in a certain way according to specific 'thinking strategies' improve brain processes related to decision-making? * Does brain functioning during decision-making relate to real-world choices to engage in activities? Researchers will compare brain functioning and decision-making on computer tasks of gambling after participants have been trained to use a positive thinking strategy. They will compare what is different in the brain and behavior when participants use this strategy and when they do not. Participants will also answer brief surveys about activities and feelings for a week in their daily lives. Participants will: * Complete several hours of clinical interviewing, cognitive tests, and surveys of about symptoms, experiences, and personality * Complete computer tasks about gambling decisions during MRI brain scanning and while having their visual attention measured using eye-tracking * Complete brief surveys about their activities and feelings 5 times a day for 1 week using a cell phone. Each survey only take several minutes.
CONDITIONS
Official Title
Decision-Making in Schizophrenia: A Combined Neuroimaging and Experience Sampling Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 50 years
- Capacity to provide informed consent
- Fluent in English
- Willing and able to follow study requirements and complete procedures
- Cognitive ability with estimated IQ over 70
- For schizophrenia group: diagnosed with schizophrenia or schizoaffective disorder
- For control group: matched to schizophrenia group by age, sex, race/ethnicity, and education level
You will not qualify if you...
- Intoxication from alcohol or illicit drugs at study visits
- Current regular use of substances other than nicotine, alcohol, or cannabis
- Long history of severe substance use disorder except nicotine/tobacco
- Significant physical health or neurological disorders
- History of traumatic brain injury with loss of consciousness or neurobehavioral effects
- Electroconvulsive therapy within one month before participation
- History of seizures or epilepsy
- Untreated or unstable psychiatric or medical conditions
- Intellectual disability
- Contraindications for MRI scanning
- For control group: history of substance use disorder or significant psychiatric disorder in self or first-degree relative
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Center for Advanced Human Brain Imaging Research
Piscataway, New Jersey, United States, 08854
Actively Recruiting
Research Team
P
Pariya Chanthasensack, BS
CONTACT
J
John Purcell, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here